ArticleJournal of medicinal chemistry2013

Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands.

Henry I Mosberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.